Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes

Background: Nucleolin (NCL) is a multifunctional protein with oncogenic properties. Anti-NCL drugs show strong cytotoxic effects, including in triple-negative breast cancer (TNBC) models, and are currently being evaluated in phase II clinical trials. However, few studies have investigated the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen Van Long, Flora, Lardy-Cleaud, Audrey, Bray, Susan, Chabaud, Sylvie, Dubois, Thierry, Diot, Alexandra, Jordan, Lee B., Thompson, Alastair M., Bourdon, Jean-Christophe, Perol, David, Bouvet, Philippe, Diaz, Jean-Jacques, Marcel, Virginie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210205/
https://www.ncbi.nlm.nih.gov/pubmed/30360377
http://dx.doi.org/10.3390/cancers10100390

Ejemplares similares

Ejemplares similares